Importantly, while the c-MYC protein is overexpressed in ∼70% of human cancers, typically only ~20% of tumors harbor c-MYC gene amplifications or translocations and thus it remains possible that aberrant c-MYC turnover/degradation may account for this discrepancy [63]. Here, MYC is linked to cancer.